Central Pharmaceutical JSC No2 (HSTC:DP2) Net Income From Continuing Operations : ₫0.00 Mil (TTM As of . 20)

View and export this data going back to 2017. Start your Free Trial

What is Central Pharmaceutical JSC No2 Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Central Pharmaceutical JSC No2's net income from continuing operations for the six months ended in . 20 was ₫0.00 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in . 20 was ₫0.00 Mil.

Central Pharmaceutical JSC No2 Net Income From Continuing Operations Historical Data

The historical data trend for Central Pharmaceutical JSC No2's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Central Pharmaceutical JSC No2 Net Income From Continuing Operations Chart

Central Pharmaceutical JSC No2 Annual Data

Trend

Net Income From Continuing Operations

Central Pharmaceutical JSC No2 Semi-Annual Data

Net Income From Continuing Operations

Central Pharmaceutical JSC No2 Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Net Income From Continuing Operations for the trailing twelve months (TTM) ended in . 20 was ₫0.00 Mil.

Central Pharmaceutical JSC No2 (HSTC:DP2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Central Pharmaceutical JSC No2 (HSTC:DP2) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 9 Tran Thanh Tong, Bach Dang Ward, Hai Ba Trung District, Hanoi, VNM

Website

https://www.dopharma.vn

Central Pharmaceutical JSC No2 is engaged in the Trading of medicinal materials, pharmaceutical materials, chemicals, essential oils, modern medicines, traditional medicine drugs, cosmetics, and nutritious foods. Some of its products include Gentamycin injection solution 80; Genatreson Skin Cream; Ferimax Hard Capsules and others.

Central Pharmaceutical JSC No2 (HSTC:DP2) Headlines

No Headlines